Collegium Pharmaceutical, Inc. (COLL)
46.73
-0.30
(-0.64%)
USD |
NASDAQ |
Dec 10, 11:49
Collegium Pharmaceutical EPS Diluted (Quarterly): 0.8385 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.4153 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Altimmune, Inc. | -0.2126 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
| Viking Therapeutics, Inc. | -0.8083 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 31.51M |
| Revenue (Quarterly) | 209.36M |
| Total Expenses (Quarterly) | 177.85M |
| Enterprise Value | 2.117B |
| Gross Profit Margin (Quarterly) | 61.70% |
| Profit Margin (Quarterly) | 15.05% |
| Earnings Yield | 3.44% |
| Operating Earnings Yield | 9.19% |
| Normalized Earnings Yield | 3.662 |